Therapeutic Areas
Fresenius Biotech develops and markets innovative biopharmaceutical products for the treatment and prevention of serious diseases in two major therapeutic areas:

• Rejection reactions in organ and stem cell transplantations 
• Oncological indications

Treatment Approaches
A characteristic of our products is the immunotherapeutic mode of action: through the use of pharmaceuticals, the biological reaction of the body’s own immune system is utilized for treating the underlying primary disease.

Both the trifunctional antibody Removab and the polyclonal antibody ATG-Fresenius S apply this mode of action for treatment of different primary diseases.


Information on our prescription medicines
In European countries, we are only allowed to provide information on prescription medicines to healthcare professionals. For more information on our prescription drugs, please consult your physician.